Fibroblast growth factors mediate cellular responses by interacting with a family of related receptor tyrosine kinases (FGFRs). We have previously shown that FGFR-1, but not of FGFR-4, ectopically expressed in BaF3 lymphoid cells allows for proliferation in response to FGFs, and that the intracellular signaling halves of these two receptors distinguish their mitogenic potentials (Wang et al., 1994) . In order to map the residues which functionally distinguish these receptors, a panel of chimeric receptors whose cytodomains bear dierent contributions from FGFR-1 and FGFR-4 were constructed and characterized. The behavior of these chimeras implicate amino acids from both the kinase insert and kinase domains in receptor-mediated proliferation. Speci®cally, two tyrosine residues present in the short kinase insert domain of FGFR-1 and absent from FGFR-4 are a necessary, but not sucient, component of a fully mitogenic receptor, suggesting that tyrosine phosphorylation in the kinase insert promotes a mitogenic signaling pathway. A strongly mitogenic receptor also requires one or two FGFR-1-speci®c residues from either of two regions within the kinase domain. One of these regions is within the kinase domain's activation loop, where FGFR-1, but not FGFR-4, bears a key aspartate residue. The mitogenic potentials of FGFR-1, FGFR-4, and the chimeric receptors strongly correlates with the magnitude of ligand-induced receptor autophosphorylation in BaF3 cells. We discuss mechanisms by which these few key amino acid dierences may determine the levels of ligand-induced FGF receptor autophosphorylation and mitogenic potency.
Introduction
The activation of receptor tyrosine kinases by polypeptide ligands is a broadly utilized mechanism of intercellular communication for the development and maintenance of higher organisms. Ligand-induced oligomerization of monomeric receptors or conformational alteration of dimeric receptors and subsequent receptor autophosphorylation are apparently universal mechanisms by which these receptors initiate signal transduction (Ullrich and . The subsequent recruitment of speci®c intracellular protein signal transducers to activated receptor kinases, which is frequently mediated by the anity of receptor phosphotyrosine peptide epitopes for src homology 2 (SH2) or phosphotyrosine binding (PTB) domains on recruited proteins (Koch et al., 1991; Blaikie et al., 1994; Craparo et al., 1995; Kavanaugh and Williams, 1994) , triggers downstream events by either enzymatic activation of the transducer via tyrosine phosphorylation or conformational change (Mohammadi et al., 1991; Myers et al., 1992) , translocation of the transducer's activity from the cytosol to the plasma membrane (Buday and Downward, 1993; RozakisAdcock et al., 1993) , or association of the tyrosine phosphorylated transducer with yet other proteins Tauchi et al., 1994) . Dierent receptor tyrosine kinases achieve distinct signaling capabilities in part through dierences in the sequences of their cytodomains.
The ®broblast growth factors (FGFs) are a family of structurally related ligands which induce biological responses on a wide range of cells through the activation of FGF receptor tyrosine kinases (FGFRs) encoded by four distinct genes (Johnson and Williams, 1993) . The activities of several signaling proteins have been implicated in FGF-induced responses, including phospholipase Cg (PLCg) (Mohammadi et al., 1991) , SHC (Vainikka et al., 1994; Wang et al., 1994) , and components of the RAS G-protein/MAP kinase pathway (McNicol et al., 1993; Shaoul et al., 1995; Szeberenyi et al., 1990; Vainikka et al., 1994; Wang et al., 1994) which are likely activated by a Grb-2/SOSassociated 85 ± 90 kDa tyrosine phosphorylated protein (Klint et al., 1995; Mohammadi et al., 1996a) related or identical to SNT (Rabin et al., 1993; Wang et al., 1996) . PLCg becomes phosphorylated and activated following association with a phosphotyrosine-bearing epitope near the C-terminus of FGFR-1 (Mohammadi et al., 1991) , but the mitogenicity of this receptor does not require PLCg activity (Mohammadi et al., 1992; Peters et al., 1992) . SNT-like protein weakly associates with activated FGFR-1 , but tyrosine phosphorylation of this protein does not require any receptor autophosphorylation sites other than those in the kinase activation loop (Klint et al., 1995; Mohammadi et al., 1996a) . Six other tyrosine autophosphorylation sites in FGFR-1 have been documented (Mohammadi et al., 1996a) , but target proteins which may interact with these other receptor autophosphorylation sites have not been identi®ed.
While the intracellular domains of FGFRs are highly related to one another, dierences in the signaling and functional capabilities of FGFRs have been observed. When FGFR-1 is ectopically expressed in FGFR-negative rat L6 myoblasts, FGF induces tyrosine phosphorylation of PLCg, SHC, ERK-1 and ERK-2, and SNT-like protein, while FGF treatment of FGFR-4 transfected L6 cells is less eective at promoting tyrosine phosphorylation of these proteins (Shaoul et al., 1995; Vainikka et al., 1994; Wang et al., 1994) . The receptors also have dierent capacities to promote FGF-dependent proliferation when expressed in BaF3 lymphoid cells. While FGF induces a strong proliferative response in BaF3/FGFR-1 cells (Ornitz and Leder, 1992; Wang et al., 1994) , a weaker response is seen in BaF3/FGFR-3 cells (Ornitz and Leder, 1992) , and no growth is achieved in BaF3/FGFR-4 cells (Wang et al., 1994) . The BaF3 cells expressing FGFR-4 also fail to undergo ERK phosphorylation or induction of fos and jun gene expression upon FGF challenge (Wang et al., 1994) .
Here, we describe the properties of a panel of FGF receptors whose cytoplasmic domains are chimeras of the related FGFR-1 and FGFR-4 sequences. These studies de®ne a few key amino acid dierences between FGFR-1 and FGFR-4 within the kinase and kinase insert domains which distinguish the mitogenic potentials of these receptors expressed in BaF3 cells.
Results
Sequence dierences in the juxtamembrane and tail regions of FGF receptors do not distinguish the mitogenic potentials of FGFR-1 and FGFR-4
We have previously shown that interleukin-3 (IL-3)-dependent BaF3 cells expressing FGFR-1 or a chimeric receptor bearing the cytoplasmic domain (cytodomain) of FGFR-1 and the extracellular domain of FGFR-4 proliferate in response to FGF in the absence of IL-3, while BaF3 cells expressing FGFR-4 die in IL-3 free, FGF-containing medium (Wang et al., 1994) . Based upon dierences in the cytodomain sequences of FGFR-1 and FGFR-4 (Figure 1a ), we constructed a panel of receptors each chimeric in their cytodomains, and all bearing the extracellular and transmembreane domains of FGFR-4 (Table 1 and Figure 1b) . The mitogenic potential of receptors expressed in BaF3 cells were tested in two assays. In the colony formation assay, receptor expression vectors were co-electroporated with a neomycin resistance plasmid into BaF3 cells, which were later plated into 96-microwell plates containing acidic FGF in the absence of IL-3 and, to control for transfection eciency, into microwells a b Figure 1 Receptor sequence alignments. (a) Sequences of the murine FGFR-1 and FGFR-4 cytoplasmic domains (Mansukhani et al., 1990; Stark et al., 1991) are aligned and numbered within their kinase and kinase insert regions. The actual residue number for the ®rst and last cytoplasmic residues for each receptor are given in parentheses. Residues found in FGFR-4 and none of the other three FGFRs (Mansukhani et al., 1992; Keegan et al., 1991) are marked`*', and other residues which dier between FGFR-4 and FGFR-1 are marked`6'. The kinase insert sequences of FGFR-2 and FGFR-3 are also shown. JM, juxtamembrane region; N, Nterminal half of kinase domain; I, kinase insert; C, C-terminal half of kinase domain; T, tail. (b) Schematic diagram of FGFR-1 and FGFR-4 cytoplasmic domains. The subdomains are marked in capital letters for FGFR-1 and small letters for FGFR-4. Amino acid residues which are individually exchanged or mutated in chimeric receptors (Table 1) are indicated in single letter code, along with their actual residue numbers (in parentheses) and kinase domain residue number containing IL-3 + G418. Both FGF-dependent and G418-resistant colonies were scored after 12 days of culture. In the cell proliferation assay, individual or pooled G418-resistant clones from these transfections were screened for FGF receptor expression by immunoprecipitation and Western blot analysis of cell lysates, and receptor-expressing clones or pools were seeded into microwells, cultured for 3 days (individual clones) or 4 days (pooled clones) in the presence of dierent concentrations of acidic FGF, and viable cells monitored by MTT assay. The mitogenic potential of several chimeric receptors demonstrate that sequence dierences in the juxtamembrane and C-terminal tails do not noticeably account for the dierential ability of FGFR-1 and FGFR-4 to mediate FGF-dependent growth. As shown in experiments 1 and 6 of Table 2 , chimeric receptors whose FGFR-4 components include juxtamembrane domain alone (NICT) or together with tail domain (NICt) give as many FGF-dependent colonies upon transfection as does a receptor with a complete FGFR-1 cytodomain (FR4/R1C), while another chimera bearing FGFR-4 kinase and kinase insert domains and FGFR-1 tail domain (nicT) has no mitogenic potential. Consistent with these ®ndings, clones or pools of G418 resistant cells stably expressing either FR4/R1C or NICT receptors proliferate comparably in response to FGF, while an FGFR-4 expressing clone survives no better than parental BaF3 cells in response to FGF ( Figure  2) . Therefore, the kinase or kinase insert domains of FGFR-1 must bear residues required for mitogenesis which are not shared by FGFR-4.
Tyrosines in the kinase insert region of FGFR-1 are necessary for a fully mitogenic receptor
The cytodomains of FGFR-1 and FGFR-4 most strikingly dier in their 14 amino acid residue kinase insert regions (residues 105 ± 118), including the presence of two FGFR-1 tyrosine residues not shared by FGFR-4 ( Figure 1a ). (In this study, amino acid residues are numbered beginning with the kinase domain so that corresponding residues in FGFR-1 and FGFR-4 kinase and insert domains are numbered identically). Receptor chimeras bearing substitutions in the kinase insert illustrate the critical function of this region in mediating the mitogenic response. The NiCT chimera bearing FGFR-1 kinase and tail domains and the FGFR-4 kinase insert is only weakly mitogenic, giving rise to a few small colonies upon transfection (Table 2 , experiments 1, 2, 3 and 6), and a clone or pooled clones of NiCT-expressing cells proliferate slowly in response to FGF (Figure 2 ). Compared to the fully mitogenic NICT construct, a chimera with mutations in both FGFR-1 kinase insert tyrosines (NICT/Y106L/Y108P) is also less ecient at inducing FGF-dependent colonies (Table 2 , experiments 2, 3, 6, Figure 2 ), while chimeras with individual mutations of these tyrosines (NICT/Y106L and NICT/Y108P) are less aected (Table 2, experiment 2).
The above experiments do not rule out the possibility that the dierent activities of FGFR-1 and FGFR-4 is due to a growth inhibitory eect of FGFR-4's kinase insert residues leucine-106 and proline-108 as opposed to the stimulatory eect of FGFR-1's kinase 
Sequence composition of FGFR-1/FGFR-4 chimeric receptors. The names of each chimera re¯ect the parental receptors' contributions to kinase N region (N,n), KI region (I,i), kinase C region (C,c), and tail (T,t) (FGFR-1 component capitalized, FGFR-4 component lower case) and individual residue exchanges. FGF receptor kinase and kinase insert residues are numbered as shown in Figure 1 . FR1, FGFR-1; FR4, FGFR-4 insert tyrosines. We therefore analysed the eect of the more conservative tyrosine to phenylalanine mutations in the FGFR-1 kinase insert upon colony forming potential. A chimeric receptor, FR31b, bearing the ectodomain of FGFR-3 and the kinase and kinase insert domains of FGFR-1 was compared to a derivative receptor, FR31b-YYFF, in which both kinase insert tyrosines were mutated to phenylalanines (both receptor vectors provided by J Xu and D M Ornitz). As shown in Table 2 , experiment 7, mutation of FR31b's kinase insert tyrosines to phenylalanines virtually abolishes the receptor's ability to mediate FGF-induced colony formation upon transfection. These data implicate the tyrosine residues of the kinase insert in cell proliferation, potentially by serving as critical receptor autophosphorylation sites. FGF-dependent, IL-3 independent BaF3 colony formation following receptor transfection. For FGFR-4/FGFR-1 chimeric receptor constructs (experiments 1 ± 6), a ligated mixture of 5 mg S®I-linearized pSRa-neo and 15 mg pMX vector bearing receptor cDNA was electroporated into BaF3 cells; for FGFR-3/FGFR-1 chimeric receptor constructs in the MIRB expression vector bearing an IRES neo gene (experiment 7), 20 mg NotI-digested and religated plasmids were used for electroporation. After a 48 h recovery period, cells were seeded into microwells containing acidic FGF (10 ng/ml) and heparin (10 mg/ml) or containing G418 (400 mg/ml) and IL-3 (1 ng/ml) and cultured 12 days before scoring for positive wells. Each column in the table shows the number of FGF-selected colonies among 3610 6 seeded cells (experiments 1 ± 6) or among 7610 6 seeded cells (experiment 7). Each box also shows (in parentheses) the number of G418-resistant colonies among 5610 5 cells (experiments 1 ± 5) or among 10 6 seeded cells (experiments 6, 7). For the data within each individual experiment, chi-square analyses were used to test the signi®cance of dierences in FGF-dependent colony formation between dierent receptor constructs, using G418-resistant colony formation as an internal standard. FGF-dependent colony forming eciency for each receptor was tested for signi®cant dierence versus eciency of either 
Aspartate-170 in the FGFR-1 kinase activation loop is important for mitogenesis
The kinase insert is not the only region where dierences in sequence in¯uence receptor mitogenicity. The weak growth response achieved by chimeras bearing FGFR-4 kinase domain and FGFR-1 kinase insert region (nIct and nIcT) ( Table 2 , experiments 2 ± 6, and Figure 2 ) demonstrate that the highly related kinase domains of FGF receptors bear sequence dierences which in¯uence receptor mitogenic potential. Chimeric receptors nICt and nICT (Table 1 , Figure  1b ), whose FGFR-1 contributions include the kinase insert region and the portion of the kinase domain Cterminal to the insert (`C' region), are strongly mitogenic (Table 2 , experiments 1, 2, 3 and 6, and Figure 2 ). To identify the amino acid dierences in the C region which in¯uence receptor function, four chimeras bearing the FGFR-1 kinase insert and dierent portions of the C region (Table 1) were constructed and analysed. The high colony-forming eciency of nI C / c t-2 and nI C / c t-3, but not of nI C / c t-1 and nI C / c t-4 (Table 2, experiment 3) localized the region of functionally signi®cant sequence dierential to a small portion of the C region between amino acid residues 154 ± 182. These portions of the FGFR-1 and FGFR-4 kinases dier by only four amino acid residues, and only two of these dierences represent non-conservative substitutions (Figure 1a ). To determine whether either of these two residues were functionally signi®cant, chimeras nIct/D158N and nIct/G170D were constructed bearing FGFR-1 kinase insert and FGFR-4 kinase domain in which either aspartate-158 or glycine-170 were mutated to the corresponding FGFR-1 residues asparagine-158 or aspartate-170 (Table 1, Figure 1b) . While the D158N substitution had no functional consequence, the nIct/ G170D receptor was highly mitogenic in both the colony formation (Table 2 , experiments 4 and 6) and cell proliferation (Figure 2 ) assays. A reciprocal chimeric receptor further illustrated the importance of aspartate-170 for mitogenic function. As compared with strongly mitogenic receptors bearing FGFR-1 derived kinase insert and C regions (nICt or nICT), mutation of asparagine-158 to aspartate (nICT/ N158D) did not dramatically aect mitogenicity, while mutation of aspartate-170 to glycine (nICT/D170G) virtually destroyed receptor-mediated colony forming activity (Table 2 , experiments 4 and 6) and cell proliferation (Figure 2 ).
Methionines in the N-terminal half of FGFR-1 kinase are important for mitogenesis
Chimeric receptors NIct and NIcT, whose FGFR-1 contributions include the kinase insert region and the portion of the kinase domain N-termianl to the insert (`N' region), generated more FGF-dependent colonies and cell proliferation than did parallel receptors nIct and nIcT bearing the FGFR-4 N region (Table 2 , experiments 3, 5 and 6, and Figure 2 ). Inspection of amino acid dierences between FGF receptors in the KN region suggested several functionally signi®cant residues. These dierences included two FGFR-1 tyrosines (positions 86 and 95) not present in FGFR-4 and two methionine residues (positions 57 and 60) present in FGFR-1, -2, and -3 but not in FGFR-4 (Figure 1 ). Receptor chimeras were constructed bearing FGFR-1 kinase insert and FGFR-4 kinase domain in which one or two targeted residues in the N region were converted to their FGFR-1 counterparts (Table 1, Figure 1b ). These new constructs were compared with weakly mitogenic nIct (bearing FGFR-4's N region) and more strongly mitogenic NIct (bearing FGFR-1's N region) chimeras to identify the amino acid dierences in the N region which in¯uence mitogenic potential. As shown in Table 2 , experiments 5 and 6, only the double mutation of FGFR-4's valine-57 and leucine-60 to methionines (nIct/V57M/L60M) resulted in an increase in colony-forming eciency. Consistent with these ®ndings, a clone or pooled clones Lysates were subjected to immunoprecipitation with antibodies against either the FGFR-1 or FGFR-4 C-terminus, electrophoresed through SDS -7.5% polyacrylamide gels, Western blotted and probed with either antiphosphotyrosine monoclonal antibody (upper row) or homologous FGFR antibodies (middle row), and detected using peroxidaseconjugated secondary antibodies and ECL chemiluminescence. In parallel, growth factor-and serum-starved cells were further incubated for 3 h in factor-free medium containing 3 mM Na 3 VO 4 before 5 min challenge in medium with or without FGF. FGFR immunoprecipitates were electrophoresed, Western blotted, and probed with anti-phosphotyrosine (lower row). The electroporetic of BaF3 cells expressing nIct/V57M/L60M proliferated in response to FGFs far better than cells bearing nIct receptors without these N-region methionine substitutions (Figure 2 ).
Mitogenic potentials of native and chimeric FGF receptors correlate with levels of receptor tyrosine phosphorylation in vivo
We had previously reported that FGFR-1 and FGFR-4 in BaF3 cells undergo similar, albeit weak, levels of autophosphorylation in response to FGFs (Wang et al., 1994) . Those studies had analysed FGF-induced receptor phosphorylation after overnight IL-3 deprivation. Since such extensive cell starvation may signi®cantly alter the physiology of BaF3 cells, we have reevaluated the levels of receptor tyrosine phosphorylation following a much briefer (2 h) period of IL-3 and serum starvation. Receptors in lysates from FGF-stimulated and unstimulated cells were immunoprecipitated, electrophoresed, Western blotted, and probed with either antiphosphotyrosine antibody ( Figure 3a , upper row) or with anti-receptor antibodies ( Figure 3a , middle row). Under these starvation and stimulation conditions, dramatic dierences in receptor autophosphorylation were observed. Whereas a mitogenic receptor bearing the complete FGFR-1 cytodomain (FR4/R1C) underwent strong FGF-induced tyrosine phosphorylation, autophosphorylation of non-mitogenic FGFR-4 was virtually undetectable. When chimeric receptors were analysed for receptor phosphorylation, there was a strong positive correlation between receptor mitogenicity and in vivo autophosphorylation potential. Among the receptors immunoprecipitated with FGFR-1 antibodies, the highly mitogenic FR4/R1C, NICT, and nICT receptors underwent strong FGF-dependent autophosphoryaltion, while the weakly mitogenic nICT/D170G and NiCT receptors autophosphorylated to a far lesser extent (Figure 3a , top row), despite similar expression levels for all receptors (Figure 3a , middle row). Among the receptors immunoprecipitated with FGFR-4 antibodies, the non-mitogenic FGFR-4 showed undetectable autophosphorylation (weak autophosphorylation was observed upon longer exposure), the weakly mitogenic nIct chimera bearing the FGFR-1 kinase insert underwent weak autophosphorylation, while the more highly mitogenic nIct/G170D additionally bearing the key aspartate residue in the kinase Cregion or nIct/V57M/L60M bearing methionine substitutions in the kinase N region autophosphorylated more extensively (Figure 3a ,b, individual clones and pools, respectively). Hence, changes in the receptor kinase insert and kinase domain which in¯uence receptor mitogenic potential concommitantly in¯uence the degree of FGF-induced receptor tyrosine phosphorylation.
While tyrosine autophosphorylation levels for FGFR-1 and FGFR-4 dier dramatically in BaF3 lymphoid cells, receptor autophosphorylation levels are similar in ®broblast and myoblast cell systems (Shaoul et al., 1995; Vainikka et al., 1994; Wang et al., 1994) . One possible basis for cell-speci®c dierences in relative levels of receptor autophosphorylation could be the dierential sensitivity of these receptors to dephosphorylation by tyrosine phosphatases present in BaF3 cells. To test this possibility, receptor-bearing cells were serum/IL-3 starved for 2 h and then treated with the tyrosine phosphatase inhibitor orthovanadate for 3 h prior to FGF stimulation. As shown in the bottom row of Figure 3a , FR4/R1C, FGFR-4, and all chimeric receptors underwent similar strong levels of FGFinduced receptor tyrosine phosphorylation following orthovanadate pretreatment. Orthovanadate was absolutely required during the lengthened pretreatment to achieve rescue of FGFR-4 autophosphorylation (data not shown). These ®ndings suggest that the mitogenic dierences among native and chimeric FGF receptors in BaF3 cells may be due in part to dierential sensitivity among receptors to inactivation by tyrosine phosphatases.
Discussion
Mutational analysis of receptor tyrosine kinase function has largely employed mutations of tyrosine autophosphorylation sites or of residues adjacent to these tyrosines. These studies have helped identify autophosphorylation sites within the receptor which stimulate kinase activity (Kato et al., 1994; Kazlauskas et al., 1991; Longati et al., 1994; Rodrigues and Park, 1994; Zhang et al., 1991) and other autophosphorylation sites critical for the recruitment of speci®c substrates to phosphotyrosine-containing receptor peptide epitopes and for mediating biological responses (Escobedo et al., 1991; Fantl et al., 1992; Margolis et al., 1990; Mohammadi et al., 1991; Stephens et al., 1994) . The identi®cation of functional dierences between evolutionarily related receptor cytodomains allows for the additional strategy of chimeric receptor analysis to map receptor domains and residues which mediate biochemical and functional responses. This approach has been used to ®nd the sequences which distinguish the functions of epidermal growth factor receptor and its relative HER-2, identifying a threonine residue in the juxtamembrane region as a site which in¯uences mitogenicity, perhaps by serving as a site for phosphorylation by serine/thereonine kinases (Di Fiore et al., 1992) . We have used the chimera strategy here to identify residues in the kinase and kinase insert domains of FGF receptor-1 which are required for eliciting growth of a reporter cell line upon FGF stimulation. Some of the functionally signi®cant receptor residues identi®ed by this method could not have been anticipated through current understanding of receptor kinase function.
One region distinguishing the mitogenic potentials of FGF receptors is the kinase insert region. Compared to mobilities of protein molecular weight standards are indicated, as are the positions of immature and mature FGF receptors (middle row) and autophosphorylated mature receptors (upper, lower rows). (b) G418/IL3-selected pools of receptor-bearing cells were assayed for FGF-induced receptor phosphotyrosine (upper row) and receptor levels (lower row) as described above the non-mitogenic FGFR-4, a chimera which replaces the FGFR-4 kinase insert with that from FGFR-1 (nIct) has weak, though detectable, mitogenic potential. Reciprocally, in comparison to the strongly mitogenic receptor bearing FGFR-1 kinase and kinase insert regions (NICT), a chimera which replaces the FGFR-1 kinase insert with its FGFR-4 counterpart (NiCT) has greatly diminished mitogenic potential. The importance of the kinase insert sequence in receptor function has been well established among the class III receptor tyrosine kinases (Ullrich and . Class III receptors for platelet-derived growth factor, macrophage colony stimulating factor, and mast cell growth factor have long kinase insert regions (80 ± 100 residues) bearing autophosphorylation sites which serve to recruit signal transducing molecules and which are required for receptor-mediated growth responses (Escobedo et al., 1991; Reedijk et al., 1992; Serve et al., 1994; van der Geer and Hunter, 1993; Yu et al., 1991) .
We have shown here that the two tyrosines in FGFR-1's short kinase insert are essential for strong mitogenic potential, since their mutation to the corresponding residues found in FGFR-4 (leucine and proline) or to phenlyalanines dramatically antagonizes receptor function. The ability of FGFR-1's two kinase insert tyrosine residues to undergo autophosphorylation in vitro and in vivo (Mohammadi et al., 1996a) strongly suggests that the tyrosine phosphorylated kinase insert of FGFR-1 mediates substrate recruitment essential to the mitogenic response in BaF3 cells. Substrate recruitment may also account for the FGFR-1 kinase insert's eect upon levels of FGF-induced receptor autophosphorylation (Figure 3 ) by steric protection against the action of tyrosine phosphatases. The importance of the kinase insert tyrosine residues is further re¯ected in the relative mitogenic potency of the four known FGF receptors in BaF3 cells; highly mitogenic FGFR-1 and FGFR-2 have two identically positioned tyrosines in their kinase inserts (see Figure 1a ) (Ornitz and Leder, 1992; Wang et al., 1994; D Clements and M Goldfarb, unpublished data) , weakly mitogenic FGFR-3 bears only one of these two tyrosines (Figure 1a ) (Ornitz and Leder, 1992; Naski et al., 1996) , while non-mitogenic FGFR-4 lacks both tyrosines in its kinase insert (Figure 1a) (Wang et al., 1994) . FGFR-1's kinase insert tyrosines are not required for FGFR-1-mediated proliferation of another cell type, L6 myoblasts (Mohammadi et al., 1992 (Mohammadi et al., , 1996a . Dierent FGF receptor sequence requirements imparted by L6 and BaF3 cells for cell proliferation may re¯ect the use of somewhat dierent signaling pathways in these two cell types, as had been previously documented in studies on PDGF receptor-mediated growth in L6 and BaF3 cells (Satoh et al., 1993) .
Another key residue distinguishing FGFR-1 and FGFR-4 mitogenic activity is within the activation loop of the kinase domain at position 170, where FGFR-1, -2, -3, and more than half of known receptor tyrosine kinases bear an aspartate residue (Hanks et al., 1988) . By contrast, non-mitogenic FGFR-4's glycine at position 170 is shared by only two other known tyrosine kinases, the TIE receptors (Maisonpierre et al., 1993) . The activation loop of receptor tyrosine kinases contains from one to three tyrosine residues which, when unphosphorylated, results in a relatively inactive kinase due, to the loop's interference with the binding of ATP or peptide substrate (Hubbard et al., 1994 , Mohammadi et al., 1996b . Ligand-induced transphosphorylation of these tyrosines induces conformational changes favorable for ATP-binding and enzymatic activity (Hubbard et al., 1994; Kato et al., 1994; Kazlauskas et al., 1991; Longati et al., 1994; Naldini et al., 1991; Rodrigues and Park, 1994; Tornqvist and Avruch, 1988; Zhang et al., 1991) . The dierence in the activation loop sequences of FGFR-1 and FGFR-4 may in¯uence receptor kinase activity in vivo by aecting the rates at which the loop undergoes ligand-dependent phosphorylation or phosphatase-mediated dephosphorylation.
Intriguingly, aspartate-170 in the FGFR activation loop is conserved in the KIT receptor tyrosine kinase, where amino acid substitutions due to spontaneously arising mutations induce mast cell tumors in rodents and humans (Nagata et al., 1995; Piao and Bernstein, 1996; Tsujimura et al., 1994 Tsujimura et al., , 1995 . These KIT oncogenic mutations replace the native aspartate residue in the activation loop with either valine or tyrosine, and oncogenesis results from constitutive, ligand-independent activity of the mutant KIT receptors. Furthermore, the mutant receptors can induce ligand-independent survival and proliferation when transfected into hematopoietic cells (Piao and Bernstein, 1996) . Hence, deviations from aspartate at a key residue in the activation loop of receptor tyrosine kinases can result in either receptor gain of function (KIT aspartate to valine or tyrosine) or loss of function (FGFR-1 aspartate to FGFR-4 glycine).
Materials and methods

Reagents
Human acidic FGF and murine IL-3 were purchased from R&D Sytems. Rabbit polyclonal antibodies against a murine FGFR-4 C-terminal peptide were prepared as described previously (Wang et al., 1994) . Rabbit antibodies against an FGFR-1 C-terminal peptide were from Santa Cruz Technology, monoclonal 4G10 antiphosphotyrosine was from Upstate Biotechnology, horse radish peroxidase-conjugated antibodies to mouse and rabbit Igs were from Promega and Sigma Chemical, respectively, and Protein G-Sepharose was from Pharmacia LKB Biotechnology.
Oligonucleotides used in this study
See Table 3 .
Construction of plasmids
Chimeric receptor cDNAs were engineered into the expression vector pMX (D Glass, unpublished data), a smaller derivative from the larger vector pvcos (Zhan et al., 1987) bearing an EcoRI cloning site between two Moloney murine leukemia virus LTR elements. The FR4/R1C chimeric receptor bearing the ectodomain of FGFR-4 and the transmembrane and cytodomains of FGFR-1 was described previously (Wang et al., 1994) . All additional FGFR-4/FGFR-1 chimeras bear the extracellular, transmembrane, and juxtamembrane regions of FGFR-4, with kinase insert (I), kinase N-and C-terminal halves (N,C), and tail (T) regions from either FGFR-1 (capitalized initial) or FGFR-4 (lower case initial) (Table 1 and Figure 1b) . For example, the niCT chimera bears FGFR-4-derived kinase N and kinase insert regions and FGFR-1 derived kinase C and tail regions. The exact amino acid compositions of all chimeras are given in Table 1 using the kinase residue numbering system shown in Figure 1 . This numbering system begins with the ®rst residue of the kinase domain, such that corresponding residues in FGFR-1 and FGFR-4 are assigned the same numbers. Chimeric cDNAs were engineered either directly in pMX vector from preexistent constructs or ®rst in pBluescriptII vector (Stratagene) and then transferred into expression vector. Polymerase chain reaction (PCR)-derived segments of chimeric cDNAs were generated with Ultma thermostable polymerase (Perkin Elmer) using 5 ± 8 thermal cycles, and were sequenced to con®rm polymerase ®delity.
Listed below are the fragments used in ligation to generate each chimera. . NICT ± (1) FGFR-4 fragment extending from 5' untranslated sequence to natural EcoRI site 17 base pairs 5' to the J/N junction, (2) 240 bp EcoRI/ApaLI FGFR-1 PCR fragment using primers A01S (creating an EcoRI site) and A02AS downstream of native ApaLI site, (3) ApaLI/SalI 1.5 kbp fragment spanning most of the murine FGFR-1 kinase domain, tail region, and 3'-untranslated sequence. . nicT ± (1) FGFR-4 fragment from 5'-untranslated sequence to PvuII site 18 base pairs 5' to the KC/T junction (codon 272), (2) 1.0 kbp PvuII/SalI FGFR-1 PCR fragment bearing FGFR-1 tail and 3'-untranslated sequences derived with primers B01S (creating a PvuII site) and vector antisense primer downstream of vector polylinker SalI site. . NICt ± (1) NICT fragment from 5'-untranslated sequence to EagI site in KC region, (2) 270 bp EagI/PvuII PCR FGFR-1 fragment bearing rest of FGFR-1 KC region using primers C01S (upstream of EagI site) and C02AS primer (creating PvuII site), (3) 0.9 kbp PvuII/SalI FGFR-4 fragment bearing tail and 3'-untranslated sequence. . NIcT ± (1) NICT fragment from 5'-untranslated sequence to BglII site nine base pairs 3' to the I/KC junction (codon 122), (2) 450 bp BglII/PvuII PCR FGFR-4 fragment bearing KC region using primers D01S (creating BglII site) and D02AS downstream of PvuII site (codon 272), (3) 1.0 kbp PvuII/SalI nicT fragment bearing the FGFR-1 tail. . NiCT ± (1) FGFR-4 fragment from 5'-untranslated sequence to XbaI site in J region, (2) 370 bp XbaI/ApaI PCR fragment using NICT template and primers E11S (upstream from XbaI site) and E12AS (creating ApaI site at codon 111), (3) 130 bp ApaI/BstEII PCR fragment using NICT template and primers E21S (creating ApaI site) and E22AS (downstream from BstEII site), (4) NICT fragment from BstEII site (codon 153) in KC region through Cterminus. The two PCR fragments generate the FGFR-4 kinase insert region by means of the FGFR-4 sequences at the 5' ends of primers E12AS and E21S. . nICT ± (1) FGFR-4 fragment from 5'-untranslated sequence to XbaI site in J region, (2) 340 bp Xba/NarI FGFR-4 fragment extending to NarI site (codon 100) 12 base pairs 5' to KC/KI junction, (3) 160 bp NarI/BstEII fragment using NICT template and primers F01S (creating NarI site) and E22AS downstream of BstEII site, (4) NICT fragment extending from BstEII site through Cterminus. . nICt ± Same as for nICT (above), except the fourth fragment is derived from NICt, extending from BstEII site through C-terminus. CGTGCCAGCCCAAAGT atatactCGGCCGATTAGCTTCATCACCTCCATCTCGGAGACCAGGTCTGGC AAATCCTTGTCGGAGG atatactCGGCCGATCATCTTCATCATCTCCATCTCGGAGACCAGGT atataatCGGCCGACACAAGAACATCATCAA GATCTTCATCACATCAT agagacaGGGCCCTTCCTGAGTGCAGGCACCCAGCAGGTTGATGAT acacacaGGGCCCCTGTACGTGATTGTGGAATATGCCGCCAAGGGAAACCTT CGGGAATACCTCCGTGCCCGGCGCCCTCCT Sense and anitsense strand primers are indicated with S and AS suxes, respectively. Residues homologous to their intended FGFR PCR templates are in bold-face, residues corresponding to sequence of the reciprocal receptor cDNA are italicized, other silent mutations (plain text) were used to create restriction enzyme cleavage sites (underlined), and 5' buer residues which are removed upon restriction enzyme cleavage of PCR products are in lower case . nIct ± (1) nICT fragment extending from 5'-untranslated sequence to BglII site (codon 121) 9 bp 3' to the I/KC junction, (2) 450 bp BglII/PvuII NIcT fragment bearing the FGFR-4 KC region, (3) 0.9 kbp PvuII/SalI FGFR-4 fragment bearing the tail region. . nI C / c t-1 ± (1) nICT fragment extending from 5'-untranslated sequence to BstEII site at codon 153 in KC region, (2) FGFR-4 fragment extending from BstEII site through C-terminus. . nI C / c t-2 ± (1) nICT fragment extending from 5'-untranslated sequence to EagI site at codon 182 in KC region, (2) FGFR-4 fragment extending from EagI site through Cterminus. . nI C / c t-3 ± (1) nICT fragment extending from 5'-untranslated sequence to BstEII site in the KC region, (2) 240 bp BstEII/SacI PCR fragment derived with NICT template and primers G01S (upstream from BstEII site) and G02AS (creating SacI site at codon 231 in the KC region), (3) FGFR-4 fragment extending from SacI site through C-terminus. . nI C / c t-4 ± (1) nIct fragment extending from 5'-untranslated sequence to BstEII site in the KC region, (2) 180 bp BstEII/BglII PCR fragment derived using FGFR-4 template and primers H01S (upstream from BstEII site) and H02AS (creating BglII site at codon 215 in the KC region, (3) NICt fragment extending from BglII site through C-terminus. . NICT/Y106L ± (1) FGFR-4 fragment from 5'-untranslated sequence to XbaI site in J region, (2) 360 bp XbaI/XhoI PCR fragment derived using NICT template and primers E11S (upstream from XbaI site) and I12AS (creating XhoI site in codon 104 two bp 5' to KC/KI boundary), (3) 150 bp XhoI/BstEII PCR fragment using NICT template and primers I21S (creating same XhoI site and the Y106L mutation) and E22-AS (downstream of BstEII site), (4) NICT fragment extending from BstEII site through Cterminus. . NICT/Y108P ± As for NICT/Y106L, except the XhoI/ BstEII PCR fragment (3) is generated using primer I21-1S (creating Y108P mutation). . NICT/Y106L/Y108P ± As for NICT/Y106L, except the XhoI/BstEII PCR fragment (3) is generated using primer I21-2S (creating Y106L/Y108P double mutation). . nICT/D170G ± (1) nICT fragment extending from 5'-untranslated sequence to BstEII site at codon 153 in the KC region, (2) 190 bp BstEII/BglII PCR fragment generated using NICT template and primers J01S (creating D170G mutation) and G02AS (downstream of BglII site at codon 215), (3) NICT fragment extending from BglII site through C-terminus. . nICT/N158D ± Same strategy as for nICT/D170G, except 190 bp PCR fragment (2) uses primers K01S (creating N158D mutation) and G02AS. . nIct/D158N ± (1) nIct fragment extending from 5'-untranslated sequence to BstEII site at codon 153 in the KC region, (2) 190 bp BstEII/BglII PCR fragment generated using FGFR-4 template and primers L01S (creating D158N mutation) and H02AS (creating BglII site at codon 215), (3) nIC/ct-3 fragment extending from BglII site to C-terminus. . nIct/G170D ± (1) nIct fragment extending from 5'-untranslated sequence to BglII site 9 bp 3' to the I/KC boundary (codon 121), (2) 190 bp BglII/EagI PCR fragment derived using nIct template and primers D01S (upstream from BglII site) and M01AS (creating G170D mutation), (3) FGFR-4 fragment extending from EagI site through C-terminus. . nIct/A49S ± FGFR-4 fragment from 5'-untranslated sequence to XbaI site in J region, (2) 230 bp XbaI/EagI PCR fragment generated using nIct template and primers E11S (upstream from XbaI site) and N12AS (creating EagI site at codon 62 and A49S mutation), (3) 180 bp EagI/BglII PCR fragment generated using nIct template and primers N21S (creating same EagI site) and N22AS
(downstream from BglII site at codon 121), (4) nIct fragment extending from BglII site through C-terminus. . nIct/V57M/L60M ± Same as for nIct/A49S, except the 230 bp XbaI/EagI PCR fragment (2) uses primers E11S and N12-1AS (creating EagI site at codon 62 and V57M/ L60M double mutation). . nIct/V73A ± (1) FGFR-4 fragment extending from 5'-untranslated sequence to BamHI site in KN region (codon 24), (2) 170 bp BamHI/ApaI PCR fragment using FGFR-4 template and primers E11S (upstream from BamHI site) and O01AS (creating V73A mutation), (3) nIct fragment extending from ApaI site in KC region through C-terminus. . nIct/C86Y/F95Y ± (1) FGFR-4 fragment from 5'-untranslated sequence to ApaI site in KN region (codon 79), (2) 130 bp ApaI/BglII PCR fragment generated using nIct template and primers P01S (creating C86Y/F95Y double mutation) and M22AS (downstream of BglII site), (3) nIct fragment from BglII site to C-terminus. . FR31b is an FGFR-3/FGFR-1 chimeric receptor bearing the FGFR-3 (IgIIIb) ectodomain and FGFR-1 kinase and kinase insert cloned into expression vector MIRB, which bears an IRES neo gene (Chellaiah et al., 1994; , while FR31b-YYFF is the same expression vector construct, except that the two FGFR-1 kinase insert tyrosines (Y106,108) have been mutated to phenylalanines. FR31b and FR31b-YYFF expression vectors were kindly provided by J Xu and D Ornitz.
BaF3/FGFR colony formation assays
BaF3 cell transfection and colony selection were essentially as described previously (Wang et al., 1994) . A ligated mixture of S®I-linearized pMX-FGFR plasmid (15 mg) and pSRaneo (5 mg) (S®I cleaves both plasmids once within the SV40 replication origin) or 20 mg NotI-linearlized and religated FR31b plasmids were electroporated into cells which were then cultured 48 h in basal medium (RPMI 1640 + 10% fetal calf serum + penicillin/streptomycin) plus 1 ng/ml IL-3 before washing and seeding into 96-cluster microwells at 2 or 5610 4 cells/well for FGF selection (10 ng/ml acidic FGF plus 10 mg/ml heparin, refed every 2 days) or at 1 or 3610 4 cells/well for G418 selection (400 mg/ml G418 plus 1 ng/ml IL-3). Colony-positive wells were scored mircoscopically after 12 days.
BaF3/FGFR cell proliferation assays
G418-selected clones were screened for FGF receptors by their ability to bind 125 I-labelled acidic FGF (Wang et al., 1994) or by immunoblotting of cell lysates with FGFR antibodies (see below). Clones selected for proliferation and biochemical assays had between 50 000 and 100 000 receptors. Alternatively, entire unscreened pools of G418-resistant clones were used directly for proliferation and biochemical assays. In BaF3/FGFR cell proliferation assays, cells were seeded at 10 4 cells/0.2 ml/microwell (0.7 mm diameter) in medium containing 10 mg/ml heparin and dierent concentrations of acidic FGF (1-300 ng/ml) or, as negative control, in medium lacking heparin and FGF. Viable cells were monitored after 3 day (clones) or 4 day (pools) culture using dimethylthiazolyldiphenyltetrazolium bromide (MTT) as described previously (Wang et al., 1994) . Relative survival and proliferation of each cell clone or pool was assessed by comparing the maximal MTT values attained for each FGF dose-response curve.
In vivo receptor phosphorylation assays
Cells were incubated for 5 min in basal medium with or without acidic FGF (200 ng/ml) and heparin (10 mg/ml) either immediately after 2 h serum/factor starvation or following an additional 3 h incubation in serum/factor-free medium containing 3 mM Na 3 VO 4 . Challenged cells were then chilled, lysed in NP-40 lysis buer, and clari®ed lysates immunoprecipitated with either FGFR-1 or FGFR-4 antibodies. Immunoprecipitates were electrophoresed through SDS-7.5% polyacrylamide gels, electroblotted to PVDF membranes (Western blot), probed with either 4G10 monoclonal anti-phosphotyrosine or with receptor antibodies, and detected using peroxidase-conjugated secondary antibodies and enhanced chemiluminescence, as previously described (Wang et al., 1994) . The more similar, low levels of FGF-induced autophosphorylation of both FGFR-1 and FGFR-4 seen previously in the absence of orthvanadate (Wang et al., 1994) as compared with these studies re¯ected the far longer serum/factor starvation time (16 h) used in prior studies.
